Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by ¹⁸F-FDG PET/CT and Biopsy: A Diagnostic Challenge

Yeong-Shin Hsiao; Shu-Chane Shen; Shih-Chuan Hsiao

doi:10.12659/AJCR.943275

22 April 2024 : Case report Taiwan

Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by ¹⁸F-FDG PET/CT and Biopsy: A Diagnostic Challenge

Mistake in diagnosis

Yeong-Shin Hsiao^1EF, Shu-Chane Shen^2BCD, Shih-Chuan Hsiao^3BCDEF*

DOI: 10.12659/AJCR.943275

Am J Case Rep 2024; 25:e943275

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 1. Imaging of initial recurrence on October 22, 2021. (A) Fluorine-18-fluorodeoxyglucose positron emission tomography/ computed tomography (18F-FDG PET/CT) scan shows diffuse homogenous low bone marrow uptake (BMU) (maximum standardized uptake value (SUVmax) 3.63 in the spine and 3.22 in the pelvis, with normal liver SUVmax 2.87). (B) Maximum intensity projection (MIP) image shows homogeneously distributed enhanced BMU.

Back to the Article

Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by ¹⁸F-FDG PET/CT and Biopsy: A Diagnostic Challenge

Your Privacy